Bill > HR4822

This bill, the Health Care Price Transparency Act of 2023, aims to improve price transparency in the healthcare system. Key provisions include: - Requiring certain hospitals, ambulatory surgical centers, and providers of imaging and clinical laboratory services to publicly disclose their standard charges and prices for various healthcare services. This includes details like gross charges, discounted cash prices, and negotiated rates with insurers. - Promoting price transparency requirements for group health plans, including requiring them to provide cost-sharing information to plan participants and publicly disclose in-network rates and other payment information. - Increasing oversight of pharmacy benefit managers (PBMs) by requiring PBMs to submit annual reports to plan sponsors on topics like rebates, fees, and drug pricing. - Limiting Medicare Part D cost-sharing for beneficiaries to the average net price of a drug, rather than the list price. - Requiring Medicare Advantage plans to establish electronic prior authorization programs and meet certain enrollee protection and transparency standards related to prior authorization. The bill also calls for various reports and studies to further evaluate and improve healthcare price transparency efforts.